TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,561,807 | -15.5% | 1,615,879 | -0.2% | 0.22% | -11.0% |
| Q2 2023 | $39,723,389 | -70.1% | 1,618,720 | -50.5% | 0.24% | -70.7% |
| Q1 2023 | $132,921,119 | -3.6% | 3,273,113 | +6.7% | 0.84% | -5.4% |
| Q4 2022 | $137,945,392 | -7.7% | 3,068,863 | -1.8% | 0.88% | -13.2% |
| Q3 2022 | $149,482,000 | -4.3% | 3,123,973 | +18.3% | 1.02% | +1.0% |
| Q2 2022 | $156,242,000 | -12.8% | 2,639,663 | +71.3% | 1.01% | +8.8% |
| Q1 2022 | $179,241,000 | -19.9% | 1,541,325 | +3.7% | 0.93% | -8.4% |
| Q4 2021 | $223,750,000 | +25.5% | 1,486,513 | -0.5% | 1.01% | +18.6% |
| Q3 2021 | $178,334,000 | +18.4% | 1,493,838 | -3.4% | 0.85% | +19.3% |
| Q2 2021 | $150,636,000 | +27.2% | 1,546,570 | +15.2% | 0.72% | +16.2% |
| Q1 2021 | $118,446,000 | – | 1,342,160 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |